Danaher Corporation $DHR Holdings Lowered by Savant Capital LLC

Savant Capital LLC cut its stake in Danaher Corporation (NYSE:DHR) by 4.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,032 shares of the conglomerate’s stock after selling 2,559 shares during the period. Savant Capital LLC’s holdings in Danaher were worth $10,118,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. WFA of San Diego LLC acquired a new stake in shares of Danaher during the 2nd quarter valued at $26,000. Howard Hughes Medical Institute acquired a new position in shares of Danaher in the 2nd quarter worth $27,000. TruNorth Capital Management LLC acquired a new stake in shares of Danaher during the third quarter worth $28,000. Tripletail Wealth Management LLC acquired a new stake in shares of Danaher during the third quarter worth $31,000. Finally, Heartwood Wealth Advisors LLC purchased a new stake in shares of Danaher during the third quarter valued at $37,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Up 1.3%

Shares of NYSE DHR opened at $219.31 on Thursday. The business has a 50 day simple moving average of $230.07 and a 200 day simple moving average of $214.68. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $242.80. The stock has a market cap of $154.91 billion, a price-to-earnings ratio of 43.51, a PEG ratio of 2.93 and a beta of 0.91. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 28th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The firm had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. During the same period in the prior year, the company posted $2.14 earnings per share. Danaher’s revenue for the quarter was up 4.6% on a year-over-year basis. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. On average, research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were given a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s dividend payout ratio is currently 25.40%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on DHR shares. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Redburn Partners set a $220.00 target price on shares of Danaher in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Danaher in a research report on Thursday, January 29th. Guggenheim boosted their price target on shares of Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a report on Friday, January 2nd. Finally, Robert W. Baird set a $251.00 price objective on shares of Danaher in a research note on Thursday, January 29th. Twenty research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $252.32.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 21,776 shares of the firm’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the transaction, the senior vice president directly owned 14,553 shares of the company’s stock, valued at $3,190,454.19. This trade represents a 59.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction on Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the transaction, the senior vice president owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. This represents a 66.34% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 30,248 shares of company stock worth $6,609,663. Insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.